Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap56.99B
Enterprise Value58.76B
P/E Ratio-50.92
PEG Ratio1.19
Price/Sales Ratio20.44
Price/Book Ratio14.79
Enterprise/Revenue23.49
Enterprise/EBITDA-102.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.4
Operating Margin-0.34
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.27

Income Statement

Revenue875.13M
Revenue/Share0.94
Gross Profit132.41M
EBITDA-188.91M
Net Income-357.9M
Diluted EPS-0.39

Balance Sheet

Total Cash180.25M
Total Cash/Share0.2
Total Debt2.8B
Total Debt/Equity2.36
Current Ratio0.75
Book Value Per Share1.25

Price History

52-Week Change-63.54
52-Week High71.71
52-Week Low18.53
Moving Average 50 Days23.17
Moving Average 200 Days34.95

Statistics

Average Volume29.03M
Shares Outstanding919.06M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.37
Last Split Factor9:5
Last Split DateApril 20, 2016
AD